Home > Insider Trading > Filing (0001209191-18-041678)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884624	Orthofix International N V	OFIX	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1669839	V. Bradley Niemann	3451 Plano Pkwy Lewisville TX 75056	President Of Global Spine	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-07-02	2,989	$0.00	26,992	No	4	A	Direct
Common Stock	Acquisiton	2018-07-03	5,000	$27.37	31,992	No	4	M	Direct
Common Stock	Acquisiton	2018-07-03	6,250	$21.78	38,242	No	4	M	Direct
Common Stock	Disposition	2018-07-03	9,100	$56.94	29,142	No	4	S	Direct
Common Stock	Disposition	2018-07-03	2,150	$57.35	26,992	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-07-03	5,000	$0.00	5,000	$27.37
Common Stock	Stock Option (right to buy)	Disposition	2018-07-03	6,250	$0.00	6,250	$21.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-07-01	2023-07-01	No	4	M	Direct
0	2017-09-26	2023-09-26	No	4	M	Direct

Footnotes

Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 2, 2018.
The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on November 9,2017.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.27 to $57.25, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.27 to $57.45, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.